A Comparative Study of Profitability of Selected Pharma Companies of India

Bhavik U. Swadia


The Indian pharmaceutical industry is growing rapidly in the number of production, value, quantity, units and there are two main things that appear to conform to the story of the full growth of the Indian economy. Second, there has been a major change in the very basic system of pharmaceutical business in India. By issuing a patent ordinance, India fulfills WTO's commitment to identify foreign product patents from January 1, 2005, the culmination of the 10-year process. In this new scenario, Indian pharmaceutical manufacturers will not be able to manufacture patented drugs, which they have been doing for a long time, though by another process. This study has been done for important evaluation of India's pharmaceutical industry. This study focus on to analyse the profitability of the selected pharmaceutical companies of India and to study the relation between the pharmaceutical companies for various measures of profitability. The study period is ten years from 2007-08 to 2016-17. Based on the study it can be seen that pharmaceutical companies had a very good profitability in 2008, while the weakest profitability of all time in year 2015.

Full Text:


DOI: https://doi.org/10.5430/jbar.v7n1p27


  • There are currently no refbacks.

Journal of Business Administration Research (Submission E-mail: jbar@sciedupress.com)

ISSN 1927-9507 (Print)      ISSN 1927-9515  (Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the 'Sciedupress.com' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.